1. Home
  2. RGNX vs CYH Comparison

RGNX vs CYH Comparison

Compare RGNX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • CYH
  • Stock Information
  • Founded
  • RGNX 2008
  • CYH 1985
  • Country
  • RGNX United States
  • CYH United States
  • Employees
  • RGNX N/A
  • CYH N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • CYH Hospital/Nursing Management
  • Sector
  • RGNX Health Care
  • CYH Health Care
  • Exchange
  • RGNX Nasdaq
  • CYH Nasdaq
  • Market Cap
  • RGNX 387.0M
  • CYH 375.1M
  • IPO Year
  • RGNX 2015
  • CYH 1991
  • Fundamental
  • Price
  • RGNX $6.76
  • CYH $2.59
  • Analyst Decision
  • RGNX Strong Buy
  • CYH Hold
  • Analyst Count
  • RGNX 9
  • CYH 7
  • Target Price
  • RGNX $32.89
  • CYH $4.10
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • CYH 2.0M
  • Earning Date
  • RGNX 05-07-2025
  • CYH 04-23-2025
  • Dividend Yield
  • RGNX N/A
  • CYH N/A
  • EPS Growth
  • RGNX N/A
  • CYH N/A
  • EPS
  • RGNX N/A
  • CYH N/A
  • Revenue
  • RGNX $83,328,000.00
  • CYH $12,634,000,000.00
  • Revenue This Year
  • RGNX $285.14
  • CYH N/A
  • Revenue Next Year
  • RGNX N/A
  • CYH $4.08
  • P/E Ratio
  • RGNX N/A
  • CYH N/A
  • Revenue Growth
  • RGNX N/A
  • CYH 1.15
  • 52 Week Low
  • RGNX $5.62
  • CYH $2.53
  • 52 Week High
  • RGNX $21.19
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • CYH 37.33
  • Support Level
  • RGNX $7.96
  • CYH $2.72
  • Resistance Level
  • RGNX $8.35
  • CYH $2.85
  • Average True Range (ATR)
  • RGNX 0.65
  • CYH 0.13
  • MACD
  • RGNX -0.04
  • CYH 0.01
  • Stochastic Oscillator
  • RGNX 13.21
  • CYH 13.24

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: